Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
US FDA grants market authorization to six on! PLUS nicotine pouch products - 2A NASA spacecraft orbiting Mars may be dead
- 3Experience Arranging: Planning for Epic Excursions
- 4Collection of 7,000-year-old ostrich eggs discovered under sand dunes in southern Israel
- 5Find Wonderful Stream Voyage Objections On the planet
- How stripping diversity, equity and inclusion from health care may make Americans sicker
- Apollo vs. Artemis: What to know about NASA's return to the moon
- Former IRGC child executioner tells ‘Post’ how he became devout Christian dissident
- RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
- Illumina unveils dataset to speed up AI-powered drug discovery
- 5 Great Youngster Care Administrations To Watch in 2024
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- 4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- Antimatter took to the road for the very first time. Here’s why it matters
